Immunohistochemical expression of cancer stem cell related markers CD44 and CD133 in endometrial cancer

Hedrick Ellenson, 2010, Endometrial carcinoma, 393 Castilla, 2011, Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma, J. Pathol., 223, 72, 10.1002/path.2802 Morrow, 1991, Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study, Gynecol. Oncol., 40, 55, 10.1016/0090-8258(91)90086-K Sehouli, 2008, New aspects of adjuvant therapy in endometrial: cancer current standards and future directions, Crit. Rev. Oncol. Hematol., 67, 204, 10.1016/j.critrevonc.2008.02.011 Visvader, 2008, Cancer stem cells in solid tumours accumulating evidence and unresolved questions, Nat. Rev. Cancer, 8, 755, 10.1038/nrc2499 Pardal, 2003, Applying the principles of stem-cell biology to cancer, Nat. Rev. Cancer, 3, 895, 10.1038/nrc1232 Szilvassy, 1990, Quantitative assay for totipotent reconstituting hematopoieticstem cells by a competitive repopulation strategy, Proc. Natl. Acad. Sci. U.S.A., 87, 8736, 10.1073/pnas.87.22.8736 Lapidot, 1994, A cell initiating human acute myeloid leukaemia after transplantation into SCID mice, Nature, 367, 645, 10.1038/367645a0 Singh, 2004, Identification of human brain tumour initiating cells, Nature, 432, 396, 10.1038/nature03128 Al-Hajj, 2003, Prospective identification of tumorigenic breast cancer cells, Proc. Natl. Acad. Sci. U.S.A., 100, 3983, 10.1073/pnas.0530291100 Mizrak, 2008, CD133: molecule of the moment, J. Pathol., 214, 3, 10.1002/path.2283 Kato, 2012, Endometrial cancer stem cells: a new target for cancer therapy, Anticancer Res., 32, 2283 Visvader, 2008, Cancer stem cells in solid tumours: accumulating evidence and unresolved questions, Nat. Rev. Cancer, 8, 755, 10.1038/nrc2499 Rutella, 2009, Cells with characteristics of cancer stem/progenitor cells express the CD133 antigen in human endometrial tumors, Clin. Cancer Res., 15, 4299, 10.1158/1078-0432.CCR-08-1883 Goodison, 1999, CD44 cell adhesion molecules, Mol. Pathol., 52, 189, 10.1136/mp.52.4.189 Naor, 2008, Involvement of CD44, a molecule with a thousand faces, in cancer dissemination, Semin. Cancer Biol., 18, 260, 10.1016/j.semcancer.2008.03.015 Mirantes, 2013, Epithelial-to-mesenchymal transition and stem cells in endometrial cancer, Hum. Pathol., 44, 1973, 10.1016/j.humpath.2013.04.009 Chew, 2012, CD133 marks for colorectal adenocarcinoma, Malays. J. Pathol., 34, 25 Hong, 2006, Significance of CD44v6 expression in gynecologic malignancies, J. Obstet. Gynaecol. Res., 32, 379, 10.1111/j.1447-0756.2006.00422.x Gun, 2012, Clinicopathological significance of fascin and CD44v6 expression in endometrioid carcinoma, Diagn. Pathol., 7, 80, 10.1186/1746-1596-7-80 Lobo, 2007, The biology of cancer stem cells, Annu. Rev. Cell Dev. Biol., 23, 675, 10.1146/annurev.cellbio.22.010305.104154 Ward, 2007, Cancer stem cells: at the headwaters of tumor development, Annu. Rev. Pathol., 2, 175, 10.1146/annurev.pathol.2.010506.091847 Friel, 2010, Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells, Reprod. Biol. Endocrinol., 8, 147, 10.1186/1477-7827-8-147 Afify, 2005, Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal hyperplastic, and neoplastic endometrium, Ann. Diagn. Pathol., l9, 312, 10.1016/j.anndiagpath.2005.07.004 Zagorianakou, 2003, Glycoprotein CD44 expression in normal, hyperplasic and neoplastic endometrium. An immunohistochemical study including correlations with p53, steroid receptor status and proliferative indices (PCNA, MIB1), Eur. J. Gynaecol. Oncol., 24, 500 Saegusa, 1998, CD44 expression innormal, hyperplastica and malignant endometrium, J. Pathol., 184, 297, 10.1002/(SICI)1096-9896(199803)184:3<297::AID-PATH995>3.0.CO;2-7 Wojciechowski, 2015, CD44 expression in curettage and postoperative specimens of endometrial cancer, Arch. Gynecol. Obstet., 291, 383, 10.1007/s00404-014-3407-1 Hofmann, 1993, A link between ras and metastatic behavior of tumor cells: ras induces CD44 promote reactivity and leads to low-level expression of metastasis specific variants of CD44 in CREF cells, Cancer Res., 53, 1516 Inoue, 2001, Current molecular aspects of the carcinogenesis of the uterine endometrium, Int. J. Gastrointest. Cancer, 11, 339, 10.1046/j.1525-1438.2001.01046.x Fujita, 1994, Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells, Cancer Res., 54, 3922 Soslow, 1998, The CD44v6-negative phenotype in high-grade uterine carcinomas correlates with serous histologic subtype, Mod. Pathol., 11, 194 Ayhan, 2001, Overexpression ofCD44 variant 6 in human endometrial cancer and its prognostic significance, Gynecol. Oncol., 80, 355, 10.1006/gyno.2000.6014 Stokes, 2002, Association of CD44 isoform immunohistochemical expression with myometrial and vascular invasion in endometrioid endometrial carcinoma, Gynecol. Oncol., 84, 58, 10.1006/gyno.2001.6470 Leblanc, 2001, Alteration of CD44 and cadherins expression: possible association with augmented aggressiveness and invasiveness of endometrial carcinoma, Virchows Arch., 438, 78, 10.1007/s004280000269 Yorishima, 1997, Expression of CD44 alternative splicing variants in primary and lymph node metastatic lesions of gynecological cancer, Hiroshima J. Med. Sci., 46, 21 Hoshimoto, 2003, CD44 variant 6 in endometrioid carcinoma of the uterus: its expression in the adenocarcinoma component is an independent prognostic marker, Pathol. Res. Pract., 199, 71, 10.1078/0344-0338-00357 Silverberg, 1990, Carcinosarcoma (malignant mixed mesodermal tumor) of the uterus: a gynecologic oncology group pathologic study of 203 cases, Int. J. Gynecol. Pathol., 9, 1, 10.1097/00004347-199001000-00001 Lopez-Garcia, 2010, Pathologic and molecular features of uterine carcinosarcomas, Semin. Diagn. Pathol., 27, 274, 10.1053/j.semdp.2010.09.005 Nakamura, 2010, Prognostic impact of CD133expression as a tumor-initiating cell marker in endometrial cancer, Hum. Pathol., 41, 1516, 10.1016/j.humpath.2010.05.006 Kyo, 2013, Endometrial cancer stem cells: are they a possible therapeutic target?, Curr. Obstet. Gynecol. Rep., 2, 1, 10.1007/s13669-012-0030-7 Haraguchi, 2008, CD133+ CD44+ population efficiently enriches colon cancer initiating cells, Ann. Surg. Oncol., 15, 2927, 10.1245/s10434-008-0074-0 Wang, 2012, Evaluation of CD44 and CD133 as cancer stem cell markers for colorectal cancer, Oncol. Rep., 28, 1301, 10.3892/or.2012.1951